Northwest Capital Management Inc Sells 110 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Northwest Capital Management Inc decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 11.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 862 shares of the biotechnology company’s stock after selling 110 shares during the period. Northwest Capital Management Inc’s holdings in Axon Enterprise were worth $512,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Public Sector Pension Investment Board raised its position in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares during the period. CIBC Asset Management Inc raised its position in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares during the period. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the third quarter worth about $221,000. Sequoia Financial Advisors LLC raised its position in Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC bought a new stake in Axon Enterprise in the third quarter worth about $814,000. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of several research reports. Northland Securities lifted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Price Performance

AXON stock opened at $513.22 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $265.32 and a one year high of $715.99. The stock has a market cap of $39.13 billion, a PE ratio of 132.62, a P/E/G ratio of 5.43 and a beta of 1.05. The firm has a 50 day simple moving average of $619.94 and a two-hundred day simple moving average of $519.86.

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock valued at $5,631,561 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.